The Vaccine and Infectious Disease Organization at the University of Saskatchewan is one step closer to establishing its Centre for Pandemic Research, thanks to a $150,000 donation from Saskatchewan Blue Cross.
The money will be used to upgrade and expand VIDO’s infrastructure as well as support research and scientific training.

During the COVID-19 pandemic, VIDO has taken a national leadership role, being the first in Canada to isolate the virus that causes COVID-19, the first in Canada to develop an animal model, and the first Canadian university organization to have a COVID-19 vaccine in clinical trials.

Saskatoon will soon be home to Canada’s Centre for Pandemic Research. The centre is expected to be completed over the next three years. It will include a new manufacturing facility, upgrades to key containment areas, new animal housing, and the recruitment of global experts.

If you would like to join Saskatchewan Blue Cross as a ‘Friend of VIDO’ by making a donation, go here .